ProShares Ultra NASDAQ Biotechnology
BIB
BIB
20 hedge funds and large institutions have $15.6M invested in ProShares Ultra NASDAQ Biotechnology in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
15% less call options, than puts
Call options by funds: $8.1M | Put options by funds: $9.51M
Holders
20
Holding in Top 10
–
Calls
$8.1M
Puts
$9.51M
Top Buyers
| 1 | +$3.9M | |
| 2 | +$2.4M | |
| 3 | +$2.08M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.36M |
| 5 |
AIG
American International Group
New York
|
+$883K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$78.3K | |
| 3 | -$5K | |
| 4 |
PFG
Piershale Financial Group
Barrington,
Illinois
|
-$3K |